Clinical Trial Update: A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence [NA]

View source ↗

Summary

A multicenter prospective trial is evaluating perioperative finotonlimab in combination with bevacizumab for patients with resectable hepatocellular carcinoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Finotonlimab

Snippet

Sponsor: Tongji Hospital | Conditions: HCC | NA | Status: ACTIVE_NOT_RECRUITING